03 November 2023

Check Up #19 - Cancer immunotherapy

Cancer immunotherapy is any treatment that uses our own immune system to fight cancer. There are several types of immunotherapy, some of which are already being used routinely, and others still mostly experimental. They are generally a second line of treatment, following chemotherapy, radiotherapy or surgery. 

02 November 2023

Champalimaud Foundation launches screening for professionals exposed to asbestos

The new programme aims to increase the detection of MPM, focusing on workers at asbestos cement factories, in Portugal, who have been exposed to asbestos since the 1960’s, and covering a total of around 200 people who have already been identified by SOS Amianto.
 

INDP STUDENTS 2023

INDP 2023

Ana Martins (Canada/Portugal)
Arina Dygay (Russia)
Arjun Aji Reeja (India)
Beatriz Sebo (Portugal)
Devanshi Shah (India)
Guillermo Martín (Spain)
Kerem Sarikaya (Turkey)
Madalena Bettencourt (Portugal)
Miguel Donderis (Spain)
Prannay J. Reddy (India)
Robert Baber (Germany)

 

INDP 2023

 

Mette Kienhorst

27 October 2023

Free Breast Cancer Screening for Women under 50, living in Lisbon

This agreement, formally signed yesterday in a ceremony that took place at the Lisbon City Hall, will allow women under 50 in the city to undergo free breast cancer screenings. This initiative, set to be implemented by the end of the year, aims to tackle the alarming rise in cancer incidence among younger women.

26 October 2023

Four COLife Researchers Receive Grants from the Chan Zuckerberg Initiative for Cutting-Edge Metabolism Research

Through the provision of these two-year collaborative research grants, the Chan Zuckerberg Initiative (CZI) programme aims to accelerate cutting-edge research and technology in metabolism and metabolic physiology. The objective of these grants is to map, measure, and integrate metabolism across different scales—from molecules and organelles to cells and tissues—deepening our understanding of human biology, and to investigate the metabolic processes that maintain physiological homeostasis.

18 October 2023

Champalimaud Foundation to Use Synthetic Biology in the Fight Against Cancer

The Champalimaud Foundation, a private non-profit research institution located in Lisbon, Portugal, has achieved a significant milestone in cancer research and pre-clinical development by obtaining exclusive rights to deploy synthetic biology technologies initially licensed from Stanford University and further developed by Refuge Biotechnologies (Refuge), a pioneering synthetic biology company specialising in cancer immunotherapy.

16 October 2023

Champalimaud Foundation scientists create health data cloud infrastructure for research for the first time in Portugal

A novel infrastructure for storing, consulting and analysing medical data will be presented at the Open Day of the Champalimaud Foundation (FC) Breast Unit, which is taking place today, October 16. It was created by the Unit's Digital Surgery Lab, a multidisciplinary team led by surgeon Pedro Gouveia, in partnership with the telecommunications company Altice and the Portuguese company BMD Software.

02 October 2023

Zoom-In on Champalimaud - 3rd Edition - Issue 8

On October 1st, people in over 150 countries across the globe will celebrate the power of music to unite and contribute towards a more peaceful, joyful, and harmonious society during International Music Day. Here at the Champalimaud Foundation, we have several budding musicians, so we asked one of them to give us some insight into combining music with science.

28 September 2023

Check Up #18 - Side effects of cancer treatments. Can we classify them?

A side-effect “is any effect of a drug, chemical, or other medicine that is in addition to its intended effect, especially an effect that is harmful or unpleasant”. 

Subscribe to People
Loading
Please wait...